PAEDIATRIC ALTERED CONSCIOUS LEVEL GUIDELINE

HOME

AIMS

SCOPE

CLINICAL QUESTIONS

EVIDENCE-BASED SEARCH

DELPHI PROCESS

RECOMMENDATIONS

COMMENTS

PARTICIPANTS

DRAFT GUIDELINE

 

MINUTES

 

Minutes of meeting 15th June, 2005

 

 

Present at meeting:  Dr David Bond                      (general paediatrician)

                                    Dr Richard Bowker               (fellow)

                                    Miss Susie Hewitt                 (general ED)

                                    Dr Monica Lakhanpaul         (guideline methodologist)

                                    Dr Stephanie Smith              (paed. ED)

                                    Prof Terence Stephenson    (chair)

                                    Dr Harish Vyas                      (PICU)

 

Apologies from:         Dr Maria Atkinson                 (fellow)

                                    Dr Jim Bonham                     (clinical chemist)

                                    Mr Gordon Denney               (lay representative/sponsor)

                                    Dr Mandy Hampshire           (primary care)

                                    Dr Ian Maconochie                (paed. ED)

                                    Sr Sue Shipston                    (emergency department practitioner)

                                    Dr John Walter                      (metabolic medicine)

                                    Dr William Whitehouse         (paed. neurologist)

 

AGENDA

 

1.      Minutes of last meeting

            The minutes of the last meeting 9th February 2005 were approved without changes.

 

  1. Overview of the final Delphi results

      The results of the third and final round of the Delphi process left the GDG with choices of recommendations (see below):

 

      (i) Bacterial meningitis: 2 statements reached consensus on how to suspect bacterial meningitis in the absence of neck stiffness:

 

            a)         Children with reduced conscious level but no neck stiffness should be suspected of having bacterial meningitis clinically if they have fever and two of the following:          

                                    rash

                                    irritability

                                    bulging fontanelle                              (75% agreement)

 

      b)         Consider bacterial meningitis in children with a reduced conscious level without neck stiffness if they have a fever, a rash, a bulging fontanelle and or they are irritable.    (83% agreement)

 

The GDG agreed that statement (a) was preferable as it gave clear instructions as to when to “suspect” bacterial meningitis. The GDG felt that the wording of statement (b) should have led to 100% agreement as bacterial meningitis should always be “considered” in these patients.

 

      (ii) Herpes simplex encephalitis: after two rounds the Delphi panel had not agreed on which signs were indicative of HSE. Several statements reached consensus agreement in the third round:

 

            Herpes simplex encephalitis should be suspected clinically in a child with a reduced conscious level (and therefore aciclovir started) if:”

 

      a) the child has focal neurological signs                                                     (84% agreement)

            b) the child has had a fluctuating conscious level for 6 hours or more    (79% agreement)

            c) the child has had two or more of the following: 

                        a prolonged convulsion with no obvious precipitating cause

                        focal neurological signs, including a focal convulsion

                        a fluctuating conscious level for 6 hours or more                           (92% agreement)

 

            d) the child has had all of the following:     

                        a prolonged convulsion with no obvious precipitating cause

                        focal neurological signs, including a focal convulsion

                        a fluctuating conscious level for 6 hours or more   (96% agreement)

 

 

      e) the child has or has been in contact with herpetic lesions       (84% agreement in round 2)

 

            f) A child with a reduced consciousness and no obvious clinical signs pointing towards the cause should be started on acyclovir(81.8% agreement in round 1)

 

The GDG decided that statements (a) and (b) included more patients than (c) or (d) and it is sensible to encourage clinicians to suspect HSE in more children than less. The statement about “prolonged convulsion with no obvious precipitating cause” in (c) and (d) is covered by statement (f), i.e. if the cause of the convulsion is not known then the cause of the reduced conscious level is not known and the child will be suspected of having HSE. The final statement will read:

 

            “Herpes simplex encephalitis should be suspected clinically in a child with a reduced conscious level if one or more of the following 4 :

                  the child has focal neurological signs

                  the child has had a fluctuating conscious level for 6 hours or more

                  the child has or has been in contact with herpetic lesions

                  the child has no obvious clinical signs pointing towards the cause”

 

 

  1. Stakeholder comments

                  The stakeholder groups were asked to comment on the draft guideline recommendations and algorithm. Their input needs to be incorporated into the guideline without undermining the Delphi consensus process.

 

(i) Hypertensive encephalopathy

                  Hypertension had not been mentioned in the guideline due to the risk of confusing hypertension of raised ICP from hypertension of hypertensive encephalopathy. However, this was pointed out by a number of stakeholders to be a flaw in the guideline. The GDG reviewed the comments made by the stakeholders and decided that guidance on hypertension is required in the algorithm and therefore is part of the scope of the guideline. If there is no evidence available to guide detection or management of hypertensive encephalopathy then the statements from the stakeholders will be used to form a consensus statement from the GDG.

 

(ii) Pharmacy comments

                  The National paediatric pharmacy group commented that the doses and infusions should be clearly stated on the algorithm. A separate page will therefore be devoted to the calculations of infusions which have been mentioned in the guideline and are not readily available in an “off the shelf” preparation.

 

(iii) PICs / APEM comments

                  They felt that oxygen should be given to all children. The Delphi panel had agreed on the statement “Children with a reduced conscious level should be treated with high flow oxygen if their oxygen saturations are less than 95%”. The GDG agreed that the statement by the Delphi panel did not prevent oxygen being given to those with oxygen saturations 95% or more. In the algorithm, a simple statement “Give oxygen” will be included to remind clinicians of the need to maintain oxygenation. The original Delphi statement will also remain.

 

(iv) APEM / RCPath comments

                        The recognition of shock does not include tachycardia. The Delphi panel agreed with the statement:

“Shock can be recognised clinically if one or more of the following signs are present in a child with reduced conscious level:

            Capillary refill time > 2 seconds

            Mottled cool extremities

            Diminished peripheral pulses 

            Systolic blood pressure is less than 5th percentile for age

            Decreased urine output <1ml/kg/hour”

The GDG agreed that tachycardia is a sign of shock and an early sign. However, the other signs of a compromised circulation are included in the Delphi statement. As the child already has a decreased level of consciousness the circulatory failure is likely to be well established and the pulse rate may even be normal or bradycardic by then. Tachycardia has therefore not been included in the definition.

 

(v) GDG comments

                  The recommendation to collect a urine sample on admission by urine bag would not be appropriate for older children. The statement has been changed from:

      “As a non-sterile urine sample is required for these tests [the core investigations], a urine bag should be in situ as soon as the patient has had monitors attached”

to:  “As a non-sterile urine sample is required for the core investigations, a technique for collecting urine should be in place as soon as the patient has             had monitors attached, e.g. urine bag, clean catch collecting device, catheter”

           

 

  1. Audit criteria

                        The list of audit criteria drawn up at the last meeting was discussed along with further suggestions from the GDG members. The final recommended audit criteria are:

 

           

Criterion

 

Exception

Definition of terms

Percentage of children with a reduced conscious level having a plasma ammonia sent

Children within one hour post convulsion.

Children with trauma not related to a medical collapse.

Plasma ammonia result should be available in the notes or on the hospital results system

Percentage of children with a reduced conscious level having a sample of urine sent to clinical pathology to be saved for later use

Children within one hour post convulsion.

Children with trauma not related to a medical collapse

Saved urine sample sent should be documented in the notes or on the hospital results system

Percentage of children with a reduced conscious level who have their respiratory rate from admission documented in the notes

 

 

Percentage of children with a reduced conscious level who have their blood pressure from admission documented in the notes

 

 

Percentage of children with a reduced conscious level who have their GCS from admission documented in the notes

 

 

Percentage of children with suspected bacterial meningitis who were treated with intravenous dexamethasone before or with the first dose of antibiotics.

 

Suspected bacterial meningitis is defined by a score of 8.5 or more using the clinical diagnostic decision rule below if the child has neck stiffness:

Symptom/sign               Score

If GCS < 9                      = 8

Neck stiffness present    = 7.5

Duration of symptoms    =

                            1 /each 24 hrs

Vomiting                          = 2

Cyanosis                           = 6.5

Petechiae                          = 4

Serum CRP                       =     CRP value (g/dl) divided by 100

                            or

if the child does not have neck stiffness but has fever and two or more of the following:

rash

irritability

bulging fontanelle

                                       

 

These audit criteria were selected as they were readily measurable and important markers of good practice. The criterion for dexamethasone given in suspected bacterial meningitis is based on level 1a evidence. These audit criteria were also selected as the GDG felt performance could be improved in these areas (personal experience).

 

  1. Implementation strategies

                  These will be further discussed at the next meeting.

 

  1. GDG comments on the algorithm

                  The new algorithm was discussed and several alterations have been suggested which will add to the clarity of the document. Recommendations based on level 1 evidence will be highlighted on the algorithm in such a way as to not affect the ease of use of the algorithm. Dr Bowker will make the necessary changes and pilot the algorithm in the next few weeks to highlight further adaptations.

 

 

The next GDG meeting is to be on the 26th August at 10am.

 

Minutes written by Dr Richard Bowker 15th June, 2005